Showing results (161-170 of 326) with videos related to
Sort By:
Pageof 33
Basic Research in Cardiology|January 1, 1992
Regulation and possible functional implications of G-protein mRNA expression in nonfailing and failing ventricular myocardiumT Eschenhagen, U Mende, M Nose, et al.Der Radiologe|May 2, 2000
[Computer-assisted oral, maxillary and facial surgery]S Hassfeld, J Brief, R Krempien, et al.American Journal of Physiology. Heart and Circulatory Physiology|July 16, 2017
Gq-activated fibroblasts induce cardiomyocyte action potential prolongation and automaticity in a three-dimensional microtissue environmentC M Kofron, T Y Kim, M E King, et al.British Journal of Pharmacology|February 1, 1992
Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failureM Steinfath, W Danielsen, H von der Leyen, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1991
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparationsH von der Leyen, U Mende, W Meyer, et al.European Journal of Clinical Pharmacology|January 1, 1995
Effect of captopril on myocardial beta-adrenoceptor density and Gi alpha-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathyH Jakob, M Sigmund, T Eschenhagen, et al.European Journal of Pharmacology|October 2, 1991
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to ratsC J Schmidt, C K Black, V L TaylorEuropean Journal of Pharmacology|August 17, 1984
In vitro release of tritiated monoamines from rat CNS tissue by the neurotoxic compound 1-methyl-phenyl-tetrahydropyridineC J Schmidt, L A Matsuda, J W GibbAIHAJ : a Journal for the Science of Occupational and Environmental Health and Safety|April 27, 2000
Carbonless copy paper: a review of its chemical components and health hazardsC J Schmidt, I R Tebbett, M W CouchArzneimittel-Forschung|April 1, 1992
Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human heartsT Bethke, T Eschenhagen, A Klimkiewicz, et al.Pageof 33